Skip to main content

Table 2 Incidence of MACCE and bleeding events in patients with an indication for OAC receiving TT after PCI-S

From: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis

Author

MACCE (%)

Bleeding (%)

 

All cause mortality

MI

Ichemic Stroke

Overall

Major

Overall

Orford JL et al.[9]

NR

NR

NR

0

3.1

9.2

Mattichak SJ et al.[10]

3

29

0

NR

NR

21Â¥

Khurram Z et al.[11]

0.9

0

0

NR

6.6

21.5

Porter A et al.[12]

NR

NR

NR

NR

1

11

Lip GYH & Karpha M[13]

NR

NR

NR

NR

0

0*

Karjalainen PP et al.[14]

8.7

10

3.2

25.1

8.2

NR

DeEugenio D et al.[15]

1

NR

NR

NR

13.5

NR

Rubboli A et al.[16]

0

0

0

0

14.3

20

Nguyen MC et al.[17]

5.1

3.3

0.7

NR

5.9§

NR

Rogacka RCA et al.[18]

3.9

1.6

NR

23.6

4.7

7.1

Ruiz-Nodar JM et al.[19]^

17.8

6.5

1.7

26.5

14.9

27.5

M.-Fernandez S et al.[20]

5.9°

NR

NR

25.5

27.4

NR

Sarafoff N et al.[21]

10.7

3.7

1.1

14.1

1.4

9.1

Maegdefessel L et al.[22]

7.1

0

0

NR

0

NR

Rossini R et al.[23]

2

NR

1

5.8

2.9

10.8

Valencia J et al.[24]

NR

NR

NR

NR

NR

NR

Gao F et al.[25]

4.4

2.9

0.7

8.8

2.9

11.8

Sambola A et al.[26]

6.8

NR

0.3

7.9

4.3

15.5

Gilard M et al.[27]

8

5

0.8

NR

5.6

18.4

Hälg C et al.[28]

NR

NR

NR

NR

6.1

NR

Halbfass P et al.[29]

NR

NR

NR

21

8

NR

Helft G et al.[30]

0

6

0

6

0

2

Olson KL et al.[31]

14.8°

0

NR

15.4

14.3

NR

Baber J et al.[32]

5.9

1.8

NR

11.8

1.1

4.6§

Persson J et al.[33]

3.6

9

NR

NR

2.3

4.1

Uchidab Y et al.[34]

8

0

4

22

18

38

Guasch E et al.[35]

NR

NR

NR

NR

0

12.1

Jang SW et al.[36]

3.6

3.6

1.2

26.2

10.7

13.1

  1. MACCE= major adverse cardiovascular and cerebrovascular events ; OAC= oral anticoagulation; TT= triple therapy;
  2. PCI-S= percutaneous coronary intervention with stent implantation; NR= not reported.
  3. ¥ transfusions * requiring hospitalization § in-hospital events ^ data are related to anticoagulated patients, 88% of whom treated with TT ° cardiovascular-related death.